Fact Check: In peer-reviewed clinical trials, Retatrutide nearly erased fatty liver disease in almost nine out o...

Claim: In peer-reviewed clinical trials, Retatrutide nearly erased fatty liver disease in almost nine out of 10 patients.

Verdict: Correct (95% confidence)

Explanation: According to a Tier 1 source from PMC, retatrutide significantly reduced liver fat in clinical trials, with more than 9 out of 10 patients experiencing a reduction in liver fat (pmc.ncbi.nlm.nih.gov). VCU Health, a Tier 8 source, reports that retatrutide wiped out liver fat in obese patients, supporting the claim's effectiveness (vcuhealth.org). Additionally, HCPLive, a Tier 9 source, states that retatrutide cleared fatty liver disease in over 85% of patients, aligning with the claim's assertion...